David P. Schenkein

Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations

Tak W. Mak, Lenny Dang, Masato Sasaki, 2010, The Journal of experimental medicine.

Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation

Fang Wang, Erica Hansen, Francesco G. Salituro, 2013, Science.

Considerations for the successful co-development of targeted cancer therapies and companion diagnostics

Jane Fridlyand, Howard I. Scher, J. Fridlyand, 2013, Nature Reviews Drug Discovery.

Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy

Hong Wu, Albert Lai, William H. Yong, 2012, Journal of Neuro-Oncology.

MLN120B, a Novel IκB Kinase β Inhibitor, Blocks Multiple Myeloma Cell Growth In vitro and In vivo

Hiroshi Yasui, Kenneth C. Anderson, Paul G. Richardson, 2006, Clinical Cancer Research.